Pancreatic Cancer Research

ResearcherNational Cancer Centre JapanActive in the last 2 years

Ryo Tsumura

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-1732-9171; OpenAlex author ID A5008380400. Sources: OpenAlex.

Their work

Papers
3
Trials
0
Grants
0
Labs led
0
Collaborators
5
Papers, trials and grants by year

2015: 1 paper · 2016: none · 2017: none · 2018: none · 2019: none · 2020: none · 2021: 1 paper · 2022: none · 2023: none · 2024: 1 paper

Papers 3

  1. Anti-tissue factor antibody conjugated with monomethyl auristatin E or deruxtecan in pancreatic cancer models. Co-author DOI 10.1111/cas.16335↗
  2. Antitumor effect of humanized anti‑tissue factor antibody‑drug conjugate in a model of peritoneal disseminated pancreatic cancer. Co-author DOI 10.3892/or.2020.7850↗
  3. Antibody fragment-conjugated polymeric micelles incorporating platinum drugs for targeted therapy of pancreatic cancer. Co-author DOI 10.1016/j.biomaterials.2014.10.069↗

Closest collaborators

The 5 strongest of 5 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Masahiro Yasunaga · 3 shared papers, 2015–2024 · strength 0.45
  2. Yasuhiro Matsumura · 3 shared papers, 2015–2024 · strength 0.45
  3. Horacio Cabral · 1 shared paper, 2015 · strength 0.04
  4. Kazunori Kataoka · 1 shared paper, 2015 · strength 0.04
  5. Jooyeon Ahn · 1 shared paper, 2015 · strength 0.04

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.